Stock 6472 BORA PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Bora Pharmaceuticals Co., LTD.

Equities

6472

TW0006472004

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
751 TWD +4.60% Intraday chart for Bora Pharmaceuticals Co., LTD. -5.53% +17.53%
Apr. 12 Bora Pharmaceuticals Co., LTD. agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd. CI
Apr. 01 Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bora Pharmaceuticals Co., LTD. agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd.
CI
Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd..
CI
Bora Pharmaceuticals USA Inc. announced that it expects to receive $1 billion in funding from Bora Pharmaceuticals Co., LTD.
CI
Bora Pharmaceuticals Co., LTD. announces an Equity Buyback for 1,000,000 shares, representing 0.99% for TWD 6,832.17 million.
CI
Bora Pharmaceuticals Co., LTD. Announces Cash Dividend for Second Half of 2023
CI
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Bora Pharmaceuticals Co., LTD. authorizes a Buyback Plan.
CI
Bora Pharmaceuticals USA Inc. announced that it expects to receive $100 million in funding from Bora Pharmaceuticals Co., LTD.
CI
Bora Pharmaceuticals Co., LTD.(TWSE:6472) added to Taiwan TAIEX Index
CI
Bora Pharmaceuticals Co., LTD. agreed to acquire Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd. for approximately $210 million.
CI
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
SunWay Biotech Co., LTD. agreed to acquire Bora Health Inc from Bora Pharmaceuticals Co., LTD..
CI
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Bora Pharmaceuticals Co., Ltd. Elects Lin Hsin-I as Independent Director
CI
Bora Pharmaceuticals Co., Ltd. Announces Cash Dividend, Payable on July 28, 2023
CI
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Bora Pharmaceuticals Co., LTD. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Bora Pharmaceuticals Co., LTD. Announces Contract Signing of the Syndicated Loan with Syndicate Bank
CI
Bora Pharmaceuticals Co., LTD. completed the acquisition of TWi Pharmaceuticals, Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6472 Stock
  4. News Bora Pharmaceuticals Co., LTD.